Drug Type Small molecule drug |
Synonyms Alovudine (USAN/INN), FLT, FddThd + [3] |
Target |
Action inhibitors |
Mechanism POLG inhibitors(DNA polymerase gamma, catalytic subunit inhibitors), RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC10H13FN2O4 |
InChIKeyUXCAQJAQSWSNPQ-XLPZGREQSA-N |
CAS Registry25526-93-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | Canada | 07 Dec 2017 | |
Acute Myeloid Leukemia | Preclinical | Sweden | 07 Dec 2017 | |
HIV Infections | Preclinical | - | - | |
HIV Infections | Preclinical | - | - | |
HIV Infections | Discovery | - | - | |
HIV Infections | Discovery | - | - |
Not Applicable | - | (Pelvic cancer patients) | bcddomzmhd(ejxifbxxov) = hzaylwkzlx gwaskccfln (qnziuxuefr, 434) | - | 01 Nov 2018 | ||
Not Applicable | - | sqseapudjd(tvtchvhasy) = pnfotsvthf grsksxedtq (ueynrigusa, 0.1) View more | - | 15 May 2015 | |||
Not Applicable | - | 15 | vsnpabkahh(nldveclivt) = jtgdbqdirr dycbqfifgh (hdcgywuvgq ) | - | 01 Jan 2002 |